Reaction Details Report a problem with these data
Target
Cannabinoid receptor 2
Ligand
BDBM50270997
Substrate
n/a
Meas. Tech.
ChEMBL_1709636 (CHEMBL4119685)
EC50
2940±n/a nM
Citation
 Qian, HY; Wang, ZL; Xie, XY; Pan, YL; Li, GJ; Xie, X; Chen, JZ Developing pyridazine-3-carboxamides to be CB2 agonists: The design, synthesis, structure-activity relationships and docking studies. Eur J Med Chem 137:598-611 (2017) [PubMed]  Article 
Target
Name:
Cannabinoid receptor 2
Synonyms:
CANNABINOID CB2 | CB-2 | CB2 | CB2A | CB2B | CNR2 | CNR2_HUMAN | CX5 | Cannabinoid CB2 receptor | Cannabinoid receptor 2 (CB2) | Cannabinoid receptor 2 (CB2R) | hCB2
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
39690.94
Organism:
Homo sapiens (Human)
Description:
P34972
Residue:
360
Sequence:
MEECWVTEIANGSKDGLDSNPMKDYMILSGPQKTAVAVLCTLLGLLSALENVAVLYLILSSHQLRRKPSYLFIGSLAGADFLASVVFACSFVNFHVFHGVDSKAVFLLKIGSVTMTFTASVGSLLLTAIDRYLCLRYPPSYKALLTRGRALVTLGIMWVLSALVSYLPLMGWTCCPRPCSELFPLIPNDYLLSWLLFIAFLFSGIIYTYGHVLWKAHQHVASLSGHQDRQVPGMARMRLDVRLAKTLGLVLAVLLICWFPVLALMAHSLATTLSDQVKKAFAFCSMLCLINSMVNPVIYALRSGEIRSSAHHCLAHWKKCVRGLGSEAKEEAPRSSVTETEADGKITPWPDSRDLDLSDC
  
Inhibitor
Name:
BDBM50270997
Synonyms:
CHEMBL4126123
Type:
Small organic molecule
Emp. Form.:
C23H36N4O
Mol. Mass.:
384.5581
SMILES:
CC(C)C(C)Nc1cc(C(C)C)c(nn1)C(=O)NC1C2CC3CC(C2)CC1C3 |TLB:27:26:24:20.21.22,THB:17:18:24:20.21.22,27:21:18.26.25:24,22:21:18:25.23.24,22:23:18:20.27.21,(60.44,-10.01,;61.77,-10.78,;61.77,-12.32,;63.1,-10.01,;63.1,-8.47,;64.44,-10.78,;65.77,-10.01,;65.77,-8.47,;67.1,-7.7,;67.1,-6.16,;68.43,-5.39,;65.76,-5.39,;68.44,-8.46,;68.44,-10.01,;67.11,-10.78,;69.77,-7.69,;69.76,-6.15,;71.1,-8.45,;72.44,-7.68,;73.64,-6.4,;74.96,-6.89,;76.36,-6.54,;76.37,-5.02,;74.97,-4.44,;73.63,-4.91,;73.94,-5.67,;73.94,-7.26,;75.35,-7.82,)|
Structure:
Search PDB for entries with ligand similarity: